110 results
Page 2 of 6
6-K
EX-10.1
ese5ip3
25 Sep 20
Current report (foreign)
4:33pm
6-K
EX-99
6222l
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
EX-99
p7kpkr5v em4
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
cfc2fgkw0gx4
28 May 20
Current report (foreign)
11:56am
6-K
EX-1
gtqcj7h
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
9srbrr0l id8v3
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99.1
55iolr4 43zuiz8f
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
wrapv
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
g6x4xsd4py8v qa
5 Feb 19
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
9:00am
6-K
EX-99.2
0042lm36m9fp7wz1
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-10.2
oamwc8i8 2w
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.3
x420w
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am